US$ 29.88
tirzepatide injection whittier Compounded Hush Medical Spa
Description
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Patients should never administer two doses within 3 days (72 hours) of each other

It is administered as a once-weekly subcutaneous injection

Your nutritional framework should remain in place

Highlights of Prescribing Information: Saxenda (liraglutide) injection, for subcutaneous use

However, caution is advised for those who have a history of pancreatitis or heavy alcohol use before starting tirzepatide
